Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids

NCT02323646 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids

Interventions

DRUG: Placebo
DRUG: Telapristone Acetate

Sponsor

Repros Therapeutics Inc.